Eplerenone is not superior to older and less expensive aldosterone antagonists

Category Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2014
Loading references information

CRD SUMMARY:

This review found that eplerenone did not appear to be more effective in improving clinical outcomes for patients with left ventricular dysfunction (heart failure) compared with older aldosterone antagonists. The conclusion appears generally appropriate but was weakened by being based on indirect comparisons and may not be applicable to all patient groups.
Epistemonikos ID: 19a650f14db94f9a50898038946c5d963f06c9bb
First added on: Jan 16, 2014